The
report “PharmaPoint: Atopic Dermatitis – US and UK Drug Forecast and Market
Analysis to 2022″ by GlobalData is now available at RnRMarketResearch.com.
Contact sales@rnrmarketresearch.com
with PharmaPoint: Atopic Dermatitis – US and UK Drug Forecast and Market
Analysis to 2022 in subject line and your contact details to purchase this
report or get your questions answered.
The collection of ‘Dermatology therapeutics’ market
research reports has a new addition of “PharmaPoint:
Atopic Dermatitis – US and UK Drug Forecast and Market Analysis to 2022e” on
RnRMarketResearch.com .
Although the past decade has seen the atopic
dermatitis market remain relatively unchanged and a saturated, highly
genericized arena, the coming decade could see the launch of the first
biologic, which will set a precedent and pave the way for others to follow
suit.
Complete
Report of Atopic Dermatitis – US Drug Forecast and Market @ http://www.rnrmarketresearch.com/pharmapoint-atopic-dermatitis-us-drug-forecast-and-market-analysis-to-2022-market-report.html
.Purchase a Report Copy @ http://www.rnrmarketresearch.com/contacts/purchase?rname=141231
.Inquire Request Sample @ http://www.rnrmarketresearch.com/contacts/request-sample?rname=141231
.
Other events that are
expected to invoke change to the previously stagnant atopic dermatitis market
include the launch of a non-steroidal topical from Anacor, AN2728, generic
erosion of branded topicals Protopic and Elidel in the US and UK, and the increasing
use of pharmacological treatments in the growing markets of India and China.
However, these classes
represent the crowded, saturated, generic portion of the US and UK atopic dermatitis
market, with little room for innovative products. That said, the reliance on
these agents will lead to an overall steady growth over the 10-year forecast
period, with respective CAGRs of 1.2% and 0.5% for corticosteroids and
moisturizers/emollients during this timeframe.
Complete
Report of Atopic Dermatitis – UK Drug Forecast and Market @ http://www.rnrmarketresearch.com/pharmapoint-atopic-dermatitis-uk-drug-forecast-and-market-analysis-to-2022-market-report.html
.Purchase a Report Copy @ http://www.rnrmarketresearch.com/contacts/purchase?rname=141236
.Inquire Request Sample @ http://www.rnrmarketresearch.com/contacts/request-sample?rname=141236
.
Scope
- Overview of Atopic Dermatitis including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
- Detailed information on the key drugs in the US and UK including product description, safety and efficacy profiles as well as a SWOT analysis.
- Sales forecast for the top drugs in the US and UK from 2012-2022.
- Analysis of the impact of key events as well the drivers and restraints affecting the US and UK Atopic Dermatitis market.
Reasons
to buy
- Understand and capitalize by identifying products that are most likely to ensure a robust return
- Stay ahead of the competition by understanding the changing competitive landscape for Atopic Dermatitis
- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
- Make more informed business decisions from insightful and in-depth analysis of drug performance
- Obtain sales forecast for drugs from 2012-2022 in the US and UK
For further
information on “PharmaPoint:
Atopic Dermatitis – US and UK Drug
Forecast and Market Analysis to 2022” report OR for any other business research / market intelligence
need on the ‘Dermatology therapeutics’
market (http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/dermatology-therapeutics .),
contact sales@rnrmarketresearch.com /
Call +1 888 391 5441.
